This compound is primarily used in the synthesis of pharmaceuticals, particularly in the development of active pharmaceutical ingredients (APIs) with piperazine-based structures. It serves as a key intermediate in the production of drugs targeting central nervous system disorders, such as antipsychotics and antidepressants. The Boc (tert-butoxycarbonyl) protecting group allows for selective reactions during synthesis, enabling precise modifications to the piperazine ring. Additionally, its chiral centers make it valuable in creating enantioselective compounds, which are crucial for drugs requiring specific stereochemistry for efficacy and safety. Its hydrochloride form enhances solubility, facilitating its use in various chemical reactions and formulations.